| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/26/1999 | US5863767 Keratinocyte growth factor fragment lacks the first 23 amino acid residues of the n-terminus of mature, full-length kgf; treatment of hyperproliferative disease of epidermis |
| 01/26/1999 | US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders. |
| 01/26/1999 | US5863764 DNA encoding a human membrane protein |
| 01/26/1999 | US5863762 Screening for antifungal agents |
| 01/26/1999 | US5863760 Protease-resistant thrombomodulin analogs |
| 01/26/1999 | US5863758 Nucleic acids encoding osteogenic proteins |
| 01/26/1999 | US5863756 Utilize recombinant pace 4 and 4.1, mammalian endopeptidases that are specific for dibasic amino acid sites; therapeutic compositions and methods employing pace 4 or 4.1 or their inhibitors are also provided |
| 01/26/1999 | US5863745 Contacting cells targeted to be killed with a cytotoxic amount of an antibody-pe40 recombinant fusion protein, wherein said antibody is a single-chain fv fragment (scfv) and said pe40 is a pseudomonas exotoxin fragment |
| 01/26/1999 | US5863739 Assay and kit for the detection of α platelet derived growth factor receptor |
| 01/26/1999 | US5863738 Tissue morphogenic protein cell surface receptors |
| 01/26/1999 | US5863735 Human transmembrane 4 superfamily protein |
| 01/26/1999 | US5863733 Genetic engineering with cells, binding dna or rna to protein and domains |
| 01/26/1999 | US5863726 Incubating cell sample in reaction mixture comprising telomerase substrate under condition such that telomerase can catalyze extension of telomerase substrate by addition of repeat sequences, replicating extended telomerase substrate |
| 01/26/1999 | US5863724 Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy |
| 01/26/1999 | US5863718 Small peptides which inhibit to T-4 receptors and act as immunogens |
| 01/26/1999 | US5863582 Washing vegetables or fruits with water treated with ion exchange resins to remove nitrate and nitrite ions, pulverizing, adding nutritional supplements |
| 01/26/1999 | US5863555 Sustained oral delivery system comprising an antidiabetic agent and a permeation enhancer in continual contact with the mucous membrane |
| 01/26/1999 | US5863552 Method of treating myofascial pain syndrome with relaxin |
| 01/26/1999 | US5863549 Methods for the sustained release of biologically active compounds |
| 01/26/1999 | US5863541 Proteins in cells |
| 01/26/1999 | US5863538 Compositions for targeting the vasculature of solid tumors |
| 01/26/1999 | US5863537 Polypeptide comprising a variable region having the amino acid sequence of the variable region selected from the group consisting of h25d2h-1, h25d2h-2, h25d2h-3, h25d2h-4 and h25d2h-5 |
| 01/26/1999 | US5863536 N-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme inhibitor for the treatment of glutamate abnormalities and associated nervous tissue ischemia in a animal and for treatment of prostate disease |
| 01/26/1999 | US5863535 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
| 01/26/1999 | US5863534 Anticoagulants and antithrombosis agent for use in a cerebrovascular disorder such as stroke, venenous thrombosis, particularly deep ones, or disseminated intravascular coagulation; novel amino acid sequences |
| 01/26/1999 | US5863532 Antitumor agents; suppression of cell division |
| 01/26/1999 | US5863530 Treating ophthalmic fibrosis using interferon-α |
| 01/26/1999 | US5863529 Suppression of demyelination by interleukin-6 |
| 01/26/1999 | US5863528 Porcine cytokines |
| 01/26/1999 | CA2002862C Cloning and expression of a protein which modulates cellular response to type i interferon |
| 01/26/1999 | CA1340350C Monoclonal antibody to the 75 kd subunit of the human interleukin-2 receptor and use thereof |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/24/1999 | CA2238658A1 Novel grea |
| 01/23/1999 | CA2238682A1 Novel asps |
| 01/23/1999 | CA2238679A1 Novel phes |
| 01/23/1999 | CA2238677A1 Novel iles |
| 01/23/1999 | CA2238674A1 Novel tetracycline resistance protein |
| 01/23/1999 | CA2238671A1 Novel bmru |
| 01/23/1999 | CA2238667A1 Novel ferrichrome transport atp-binding protein |
| 01/23/1999 | CA2238665A1 Novel reductase |
| 01/23/1999 | CA2238663A1 Novel hiss |
| 01/23/1999 | CA2238611A1 Novel lyss |
| 01/23/1999 | CA2238608A1 Novel cyss |
| 01/23/1999 | CA2211293A1 Recombinant lysostaphin analogs |
| 01/21/1999 | WO1999002991A1 Antibodies and scfv immunotoxins specific to imported fire ants, and their application |
| 01/21/1999 | WO1999002989A1 Chaperone fragments |
| 01/21/1999 | WO1999002732A1 Antisense oligonucleotide inhibition of ras |
| 01/21/1999 | WO1999002715A1 SPLICE VARIANTS OF BRCA1 AND $i(BRCA2) |
| 01/21/1999 | WO1999002714A1 Reagents and methods useful for detecting diseases of the breast |
| 01/21/1999 | WO1999002711A2 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | WO1999002710A1 Production and use of recombinant protein multimers with altered biological activity |
| 01/21/1999 | WO1999002709A1 Recombinant erythropoietin / immunoglobulin fusion proteins |
| 01/21/1999 | WO1999002704A2 Dual specifically phosphatase and methods of use |
| 01/21/1999 | WO1999002701A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002696A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | WO1999002688A1 Coffee storage proteins |
| 01/21/1999 | WO1999002687A1 Method of increasing the iron content of plant cells |
| 01/21/1999 | WO1999002686A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002685A1 Interleukin-3 gene therapy for cancer |
| 01/21/1999 | WO1999002683A1 Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression |
| 01/21/1999 | WO1999002682A1 p53 MUTANTS FOUND IN TUMORS |
| 01/21/1999 | WO1999002681A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 01/21/1999 | WO1999002680A1 New human growth regulator protein |
| 01/21/1999 | WO1999002679A1 Frazzled nucleotide sequences, expression products, compositions and uses |
| 01/21/1999 | WO1999002678A1 Wa545 compositions |
| 01/21/1999 | WO1999002676A2 Mutants of gef proteins |
| 01/21/1999 | WO1999002675A1 G-coupled receptor showing selective affinity for atp |
| 01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators |
| 01/21/1999 | WO1999002673A2 Antisense oligonucleotide sequences as inhibitors of microorganisms |
| 01/21/1999 | WO1999002665A1 Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations |
| 01/21/1999 | WO1999002664A1 Human n-arginine dibasic convertase |
| 01/21/1999 | WO1999002658A1 Inhibiting apoptosis with adenovirus rid protein |
| 01/21/1999 | WO1999002654A1 Isolation of bone and cartilage precursor cells |
| 01/21/1999 | WO1999002567A2 Compositions and methods for producing homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
| 01/21/1999 | WO1999002565A2 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | WO1999002564A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | WO1999002563A1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002560A1 Hoqbq59 |
| 01/21/1999 | WO1999002558A1 Novel pharmaceutically active compounds interacting with gtp-binding proteins |
| 01/21/1999 | WO1999002557A1 Novel pharmaceutically active compounds interacting with gtp-binding proteins |
| 01/21/1999 | WO1999002556A1 Semaphorin receptors |
| 01/21/1999 | WO1999002555A1 Novel bacteriocins, transport and vector system and method of use thereof |
| 01/21/1999 | WO1999002554A2 Human herpesvirus-7 diagnostic and immunologic reagents and use thereof |
| 01/21/1999 | WO1999002553A1 Serum immunoregulatory polypeptides and uses therefor |
| 01/21/1999 | WO1999002552A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 01/21/1999 | WO1999002551A1 Integrin binding peptide and use thereof |
| 01/21/1999 | WO1999002549A1 Polyol-amino acid compounds having anti-helicobacter pylori activity |
| 01/21/1999 | WO1999002548A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002546A1 123 human secreted proteins |
| 01/21/1999 | WO1999002545A2 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | WO1999002526A1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/21/1999 | WO1999002192A1 Method of inducing apoptosis by reducing the level of thiamin |
| 01/21/1999 | WO1999002191A1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 01/21/1999 | WO1999002190A1 Organ-specific targeting of cationic amphiphile/retinoblastoma encoding dna complexes for gene therapy |
| 01/21/1999 | WO1999002189A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 01/21/1999 | WO1999002188A1 Hen egg yolk antibodies to clostridium difficile antigens and use in therapy for pseudomembranous colitis |